| Market Cap | ₹17,940Cr |
| ROE | 15.84% |
| P/E Ratio(TTM) | 62.98 |
| EPS(TTM) | 34.79 |
| P/B Ratio | 12.69 |
| Dividend Yield | 0.07% |
| Industry P/E | 32.50 |
| Book Value | 172.67 |
| Debt to Equity | 0.01 |
| Face Value | 5 |
| Managing Director | Nareshkumar Patel |
| Founded | 2007 |
| NSE Symbol | ACUTAAS |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 68.57 | ||
| Neuland Laboratories | NA (0.00%) | 93.80 | ||
| Jubilant Pharmova | NA (0.00%) | 31.48 | ||
| SMS Pharmaceuticals | NA (0.00%) | 38.66 |